Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

From Farm to Fork, the power of phage

Phage diagnostics have potential for cost-effective detection of bacterial infections across medical, food, and agricultural industries says new review.
  • February 24, 2022
  • Actiphage

The authors provide an overview of different techniques and conclude that phage diagnostics have been proven as a rapid non-culture-based solution for detection of viable bacterial infection, including Listeria monocytogenes, Salmonella, and Escherichia coli as well as various species of mycobacteria, the causal agents of diseases including bovine tuberculosis (bTB) and Johne’s disease (MAP).

Culture-based detection is currently considered to be the gold standard for detection and identification of bacterial pathogens within the agricultural supply chain. However, for identifying mycobacterial diseases, culture-based approaches are notoriously insensitive and unreliable. Mycobacteria can take several weeks to grow, rendering them susceptible to contamination and making culture impractical as a detection tool to ensure animal health and welfare, and food security.

Culture-based work is also time-consuming, labour-intensive, and requires level 2 or level 3 containment laboratories (depending on the organism being grown). Additionally, further confirmatory tests such as polymerase chain reaction (PCR) are required, adding to the time, cost, and labour required to positively identify an organism.

As a result, non-culture molecular methods are gaining in popularity. However, direct PCR can be expensive, sensitive to inhibition and cannot discriminate between viable or dead cells. This is a particular issue when measuring the efficacy of food processing methods designed to reduce the viable pathogens.

Immunological methods such as ELISAs use antibodies to detect proteins or antigens developed in response to a pathogen so that pathogens and associated toxins can be identified. These also have limitations, particularly in sensitivity.

For Mycobacterium bovis (M. bovis) the Single Intradermal Comparative Cervical Tuberculin (SICCT) test is most widely used test in the UK. The SICCT test, although excellent as a screening tool at herd level, is extremely poor at an individual level. A lack of sensitivity means that infections in herds can persist for a long time on farms.

Furthermore, both PCR and antibody diagnostic methods require a high level of skill and a laboratory infrastructure.

Meanwhile, Whole-Genome Sequencing (WGS) is an exciting prospect in detection markets. However, the routine use of WGS as a detection tool, especially in agriculture, is prohibitively expensive for food sector industries and currently relies on culture of the organism.

It is clear that alternative detection methods are needed which are rapid, specific, and can differentiate between active and past infections. Phage-based detection methods have been developed that fulfil these requirements while keeping costs low.

Phages have evolved to infect and propagate within specific bacterial hosts, replicating at a faster rate than their host, resulting in lysis, efficiently releasing mycobacterial DNA from viable cells. This allows detection using PCR while overcoming one of the major limitations of this technique.

The authors conclude that phage-based detection methods are low cost, portable, and accessible to a wide range of users, without the need for extensive training or equipment. As such, phage-based methods have the potential to be used throughout the agricultural supply chain—from farm-to-fork—to revolutionize the detection of bacterial pathogens.

The paper: The Application of Bacteriophage Diagnostics for Bacterial Pathogens in the Agricultural Supply Chain: From Farm-to-Fork ; Helen J. Jones, Christopher G. Shield, and Benjamin M.C. Swift Published in PHAGE: Therapy, Applications, and Research Volume 1, Number 4, 2020

DOI: 10.1089/phage.2020.0042

Share:

Related posts

Loading...
TAG pipeline report on TB feat

Detecting subclinical TB – Actiphage only blood test for mycobacteria highlighted in TAG pipeline report

November 22, 2022
Actiphage is the only test in development for subclinical tuberculosis that directly detects mycobacteria in the blood, it has been revealed by the TAG pipeline report
TAG pipeline report on TB feat

Detecting subclinical TB – Actiphage only blood test for mycobacteria highlighted in TAG pipeline report

November 22, 2022
Actiphage is the only test in development for subclinical tuberculosis that directly detects mycobacteria in the blood, it has been...
ECCMID

Actiphage TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022
A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live bacteria can be detected in the blood of people with incipient TB infection.
ECCMID

Actiphage TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022
A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live...
ECCMID conference

23-26 April 2022

Novel TB diagnostics paper to be presented at ECCMID 2022

April 4, 2022
Jee-Whang Kim of Leicester Tuberculosis Research Group (LTBRG) is to present a paper in the ‘hot topics in tuberculosis’ session at ECCMID 2022
ECCMID conference

23-26 April 2022

Novel TB diagnostics paper to be presented at ECCMID 2022

April 4, 2022
Jee-Whang Kim of Leicester Tuberculosis Research Group (LTBRG) is to present a paper in the ‘hot topics in tuberculosis’ session...

Could a rapid diagnostic help reduce infection risk?

February 14, 2022
Of the 10 million individuals who became ill with 'active' TB in 2018, approximately three million were missed by health systems, according to the Centres for Disease Control and Prevention (CDC)

Could a rapid diagnostic help reduce infection risk?

February 14, 2022
Of the 10 million individuals who became ill with 'active' TB in 2018, approximately three million were missed by health...
1 2 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More